Rare ovarian cancer survivors: what happens years after treatment?
NCT ID NCT03418844
First seen Nov 01, 2025 · Last updated Jun 14, 2026 · Updated 32 times
Summary
This study looks at women who had rare ovarian cancers and are now in remission for at least two years. Researchers want to understand how chemotherapy affects their energy, heart, lungs, and overall quality of life. Participants fill out questionnaires and may have medical tests to track long-term side effects. The goal is to learn more about what survivors experience after treatment ends.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GERM CELL TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CH Fleyriat
Bourg-en-Bresse, France
-
CHRU Stasbourg Hôpital Civil
Strasbourg, France
-
CHU Besançon Jean MINJOZ
Besançon, France
-
CHU Poitiers
Poitiers, France
-
Centre Catherine de Sienne
Nantes, France
-
Centre François Baclesse
Caen, France
-
Centre Jean Perrin
Clermont-Ferrand, France
-
Centre Léon Berard
Lyon, France
-
Centre Paul Papin
Angers, France
-
GH Cochin Broca Hôtel-Dieu
Paris, France
-
HEGP
Paris, Paris, France
-
Hôpital Diaconesses-Croix St Simon
Paris, France
-
Institut Bergonié
Bordeaux, France
-
Institut Curie,
Paris, France
-
Institut Gustave Roussy
Paris, France
-
Institut Jean Godinot
Reims, France
-
Institut Paoli Calmettes
Marseille, France
-
Institut Rennais de Cancérologie
Rennes, France
-
Institut de Cancérologie de l'Ouest
Nantes, France
Conditions
Explore the condition pages connected to this study.